Feed/Companies/Azafaros

Azafaros

As of 14 Oct 2026, Azafaros has raised $146.7M across 1 verified round on record (amounts in other currencies converted to USD); latest: €132M Series B led by Forbion Growth and Jeito Capital, announced 13 May 2025.

BUILT ON

Visit site

Azafaros develops therapeutics for patients with rare metabolic disorders, particularly those affecting the lysosomal storage system.

azafaros.comLeiden, NetherlandsBiotech

LATEST ROUND

Series B

$146.7M · 2025-05-13

RAISED ON RECORD · USD

$146.7M

across 1 verified round

INVESTORS

2 leads

SOURCES

from 2 publishers

Rounds

[ 1

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series B

$146.7M · 2025-05-13

[ HISTORY ]

led by Forbion Growth, Jeito Capital

Round	Amount	Announced	Lead	Buzz
Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$146.7M €132M	2025-05-13	Forbion Growth, Jeito Capital	No recent discussion
2 sources [ VERIFIED · CORRECTED ] read against 2 sources Leads added Jeito Capital, Forbion Growth · azafaros.com

Azafaros

Rounds

Company

Rounds

Sources

Profile

Investors

Azafaros

Rounds

Profile

Sources

Series B$146.7M2025-05-132 sources

Investors

Series B$146.7M2025-05-136 investors